New England Research & Management, Inc. Emergent Bio Solutions Inc. Transaction History

New England Research & Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 16, 2021	SELL	$86.23 - $125.19 $435,461 - $632,209	-5,050 Closed	0 $0
Q4 2020 Jan 07, 2021	BUY	$79.17 - $111.47 $399,808 - $562,923	5,050 New	5,050 $452,000
Q3 2020 Oct 08, 2020	SELL	$81.91 - $134.94 $368,595 - $607,230	-4,500 Closed	0 $0
Q2 2020 Jul 15, 2020	BUY	$54.33 - $89.52 $244,485 - $402,840	4,500 New	4,500 $356,000

137

35.6M

78.7K

75.1K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $395M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

Stay updated on New England Research & Management, Inc. with notifications on news.